This article has Open Peer Review reports available.
Rubella natural immunity among adolescent girls in Tanzania: the need to vaccinate child bearing aged women
© The Author(s). 2018
Received: 25 November 2016
Accepted: 21 December 2017
Published: 3 January 2018
Rubella primary infection during early stages of pregnancy is associated with high risk of congenital Rubella syndrome (CRS). Prevention of CRS in the resource-limited countries requires multiple strategies. Here, we document the data on the magnitude of Rubella natural immunity among adolescent girls which is a crucial group in devising effective control strategies to prevent CRS.
A cross sectional study involving 397 adolescent girls was conducted in the city of Mwanza involving five secondary schools. Socio-demographic and other relevant information were collected using pre-tested data collection tool. Rubella IgG antibodies were determined using enzyme immunoassay. The presence of Rubella IgG titers of >10 IU/ml indicated natural immunity.
The mean age of the study participants was 15.18 ± 1.48 years. Of 397 girls, 340 (85.6%) and 57 (14.4%) were from secondary schools representing peri-urban and rural areas, respectively. Out of 397 girls, 90.4% (95% CI: 87-93) were found to be naturally immune with median Rubella IgG antibodies titers of 56.7 IU/ml interquartile range (IQR): 40.8-137. The median Rubella IgG antibodies titers were significantly high in adolescent girls from families with high socio-economic status (63.96 vs. 47.13 IU/ml, P < 0.001) and in adolescent girls from peri-urban areas of the city (63.33 vs. 39.9 IU/ml, P < 0.001).
The majority of adolescent girls in the city of Mwanza are naturally immune to Rubella virus. There is a need to compare the effectiveness of screening and vaccinating susceptible adolescent girls with the effectiveness of vaccinating all women of childbearing in controlling CRS in low-income countries.
Rubella virus infection and congenital Rubella syndrome (CRS) remain to be under recognized public health problems in many low-income countries including Tanzania. In the most of low and middle income countries the introduction of Rubella containing vaccine (RCV) is still not implemented . However, RCV has been widely used in high-income countries with substantial reduction of CRS [2–6]. The ultimate goal for Rubella vaccination is to reduce cases of CRS by ensuring that all women of child bearing age have protective immunity to Rubella virus.
In Tanzania, the median age of first childbirth is about 19 years  and about 28% of women are mothers at the age of 18 years . These young women are at increased risk of contracting acute Rubella virus infections as reported by Mwambe et al.,  which observed that 72% of women who were susceptible to Rubella virus infections were aged between 15 and 24 years. It should be noted that about 90% of infants usually present with CRS if infection occurs in the first trimester . Teratogenic effects and clinical manifestations of the Rubella virus have been found to decrease with gestation age at the time of vertical transmission .
In Africa, Rubella natural immunity in adolescent girls has been found to range from 55% to 80% [12–15]. Despite the high seropositivity of Rubella virus specific antibodies among adolescent girls, a substantial number of these girls reach child bearing age without acquiring natural immunity. There is no specific level of natural immunity which is required before routine introduction of RCV. The World Health Organization (WHO) recommends that wide age range campaigns should be conducted as part of RCV introduction. In addition for the effective CRS control the coverage of RCV should be more than 80% to reduce transmission to pregnant women  hence decreasing the chances of transmitting the virus to the foetus [16, 17]. According to WHO position paper  and Centre for diseases control and Prevention (CDC) , different factors have been found to be associated with Rubella immunity. A single dose of RCV in most cases result in long lasting immunity. However, in USA other evidence for Rubella immunity includes receiving more than one dose of RCV and laboratory evidence of >10 IU/ml of Rubella specific IgG antibodies . Other factors such as age, residing in rural areas and socio-economic status(SES) have not been well studied in relation to Rubella immunity but have been found to be associated with immunity in discrete studies [9, 13].
While there are only few studies [9, 19, 20] in Tanzania that have documented the magnitude of the Rubella virus infection among pregnant women, there is no data on the level of natural immunity among adolescent girls who are the main targeted population in effective prevention of CRS. Results of the current study will provide pre-vaccination data that will be important in devising effective vaccination strategies in controlling CRS.
This study was conducted in the city of Mwanza between September and October 2014 before the national Rubella vaccination campaigns and at the time of the study no routine Rubella vaccination was provided in both public and private health facilities. Using the prevalence of 89.4% of the population aged between 15 and 24 from Mwambe et al.,  a minimum sample size obtained using Kish Leslie formula was 145 girls. Considering clustering effect  we multiplied the sample size by 1.5 therefore the minimum sample required was 217. However, we enrolled a total of 397 adolescent girls.
From peri-urban areas, out of 20 secondary schools, four schools were randomly selected while out of five schools re-presenting rural areas, one was randomly selected. A total of 940 girls were present in the selected schools. The distance between peri-urban and rural areas is about 20 km. To avoid clustering of the outcome in one category/school, from each school, girls were enrolled randomly to obtain the desired sample size based on the proportion of girls in each school. All girls selected were asked to sign the consent, for those below 18 years they were asked to take the consent forms to the guardian/parents. All guardians/parents consulted agreed participation after more explanations were given by the principal investigator (PI) through telephone. A pre-tested structured data collection tool was used to collect socio-demographic and other general characteristics. After obtaining the written informed consents from participants /parents /guardians, venous blood was obtained in plain vacutainer tubes (Becton Dickinson, UK). Blood was separated to obtain sera and all sera were kept at -80 °C freezer until analysis which was done within 1 month.
Samples were screened for anti-Rubella-specific IgG antibodies using a commercial indirect enzyme linked immunosorbent assay (ELISA® Request-Awareness Technology). All assays were performed according to manufacturer’s instructions. Standard curve was obtained by calibrating the provided standards using ChemWell 2910 Automated EIA (Awareness Technology, Inc.1935 S.W. Martin Hwy. Palm City, FL 34990, and USA). The adolescent girl with anti-Rubella IgG antibody titres of >10 IU/ml was considered naturally immune.
The data were entered in the computer using excel program and analysed using STATA version 11 (STATA Corp LP, USA). Categorical variables (SES, residence, region etc.) were presented as proportions while continuous variables (age and anti-Rubella IgG titres) were summarized as means and median, respectively. Socio-economic status was defined using mother/father’s education or employment status of parents or sustainable business of the family. Before general analysis, sub-analysis was done for each factor in respect to age category to control clustering of the outcome in one variable. Education level was deleted in the multivariate analysis due to its collinearity effects with age (i.e. clustering those with high classes in older age group). We did univariate and multivariate logistic regression analyses using Random-effects logistic regression model using school as clusters to determine the independent predictors of Rubella natural immunity among adolescent girls. All factors with a p value of <0.2 in univariate analysis were subjected to multivariate random-effect logistic regression analysis. Two-sample Wilcoxon rank-sum (Mann-Whitney) test was used to compare median titres for different groups. A p value of <0.05 was considered statistically significant. The odds ratio (OR) and 95% confidence interval (CI) were recorded to describe the strength of associations.
Socio-demographic and other characteristics of the study participants
Univariate and multivariate logistic regression analyses of factors associated with IgG seropositivity among adolescent girls
IgG positivity (N, %)
14.97 ± 1.43
Predictors of rubella natural immunity
On univariate analysis, out of 300 adolescent girls with high SES, 279(93%) were naturally immune compared to 80(82.5%) of those from low SES families (p = 0.002). However, when random effect logistic regression analysis was done the association was not significant (OR 2.48, 95% CI; 0.92-6.70, p = 0.074). Furthermore, of 340 adolescent girls from peri-urban areas, 314(92%) were naturally immune compared to 78.9% of those from rural areas (p = 0.001) (Table 1). As in SES the association was not significant on the random effect logistic regression analysis (OR 2.27, 95% CI; 0.31-16.5, p = 0.415).
None of the factor was found to independently predict rubella natural immunity on multivariate random effect logistic regression analysis (Table 1).
Rubella specific IgG titers
IgG median titers and its associated factors among adolescent girls with rubella natural immunity
Median anti-rubella IgG titers (IU/ml)
Assessing the Rubella susceptibility profile of the population and the burden of CRS is crucial before the vaccination programme is introduced . Likewise, in the countries where Rubella vaccination programs are introduced surveillance for Rubella outbreaks is emphasized . This is the first study in Tanzania to assess the level of Rubella natural immunity among unvaccinated adolescent girls. The most salient finding in this study is the high level of Rubella natural immunity among adolescent girls aged between 12 and 18 years. Our findings are similar to those reported by Yadav et al., which showed high Rubella seropositivity among child bearing aged women . The other important finding in Tanzania perspective is that no significant difference in the median anti-Rubella IgG titers between adolescents aged ≤15 and those >15 years was observed. Though it might not be generalized to the entire population this study underscores the need for a bigger study to provide data that might lead to the re-visit of the cut-off age which was used during Rubella mass vaccination campaign in 2014. The results of this study cannot be generalized to represent adolescent girls in Tanzania due to the fact that it was done in one region among secondary school girls only. Nevertheless, the results can give a preliminary picture of Rubella natural immunity in Tanzania.
With the tendency of becoming pregnant at young age, our findings are of great importance because about one tenth of these girls in our setting might be susceptible to Rubella virus infection hence at risk of transmitting the virus to the fetus which may result into CRS. These findings are consistent with other studies [25–27] which showed high anti-Rubella IgG seropositivity among adolescent girls. Despite the good strategy of vaccinating children up to 18 months, for the effective CRS prevention, Tanzanian Government should consider addition strategy of vaccinating all women of childbearing age . Reduction in CRS cases will save the Tanzanian government a significant amount of money that will be used in lifetime treatment of these cases. It has been observed that the lifetime treatment of CRS can cost between 14,000USD and 200,000USD [28–30].
Adolescent girls from peri-urban had significantly higher median specific anti-Rubella IgG titers than those from rural areas this might be attributed to recurrent exposure due to high population density in peri-urban areas. However, these findings are inconsistent with previous studies [31, 32] which showed high seropositivity among girls from families with low SES and those residing in rural areas. In comparison to Kenya study by Kombich et al.,  the mean age of pupils were 11.8 years compared to 15.2 years in the current study. In Kenya study, they attributed low SES and overcrowding. This may perhaps be opposite in Tanzania whereby the majority of the population with high SES live in peri-urban areas where there is overcrowding which consequently favours Rubella virus transmission. The observation is further supported by the fact that the majority of peri-urban girls in the current study are Rubella naturally immune. These findings might be affected by lack of stringent criteria in categorizing the residence whether is peri-urban or rural areas due to lack of clear boundaries. In addition, classification of SES in developing countries is a complex issue because the education of parents or occupation might not correlate with standard of living.
A significant proportion of adolescent girls in Mwanza city have protective Rubella antibodies with only one tenth of them being susceptible to acute Rubella virus infections. There is a need to compare the effectiveness of screening and vaccinating susceptible adolescent girls to the effectiveness of vaccinating all women of childbearing age in controlling CRS in developing countries.
The authors would like to acknowledge the technical support provided by Mr. Benard Okamo, Ms. Caroline A. Minja, Mr. Daudi Dossa and Ms. Easther Pastory. We thank all staff at KAMANGA hospital, and school administrations for their support.
This study was supported by research grant from CUHAS to MMM.
Availability of data and materials
The data is available upon request and the request should be made to the Director of research and Innovation Catholic University of Health and allied Sciences.
MMM, SEM, SA and UG designed the work. MMM & MFM participated in the collection of data and specimens. MMM SDS and SEM performed serological tests. MMM, MM, BRK and SEM analysed and interpreted the data. MMM wrote the first draft of the manuscript. SA, UG, SEM and MM provided critical revision of the manuscript. All authors read and approved the final version of the manuscript.
Ethics approval and consent to participate
The protocol for conducting the study was approved by the Joint Catholic University of Health and Allied Sciences/Bugando Medical Centre (CUHAS/BMC) research ethics and review committee (CREC) with certificate no: CREC/043/2014. Consent to participate was obtained from guardians/parents and for those aged 18 years they were asked to sign informed consent.
Consent for publication
Authors declare that they have no competing interest. All authors have read and approved the final version of the manuscript before submission.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- WHO. Rubella Vaccines: WHO Position Paper. Wkly Epidemiol Rec. 2011;86(29):301–16.Google Scholar
- Tookey P. Rubella in England, Scotland and Wales. Euro Surveill. 2004;9(4):21–3.View ArticlePubMedGoogle Scholar
- Schluter WW, Reef SE, Redd SC, Dykewicz CA. Changing epidemiology of congenital rubella syndrome in the United States. J Infect Dis. 1998;178(3):636–41.View ArticlePubMedGoogle Scholar
- Noah ND, Fowle SE. Immunity to rubella in women of childbearing age in the United Kingdom. BMJ. 1988;297(6659):1301–4.View ArticlePubMedPubMed CentralGoogle Scholar
- De Haas R, Van den Hof S, Berbers G, De Melker H, Conyn-Van Spaendonck M. Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination. Epidemiol Infect. 1999;123(02):263–70.View ArticlePubMedPubMed CentralGoogle Scholar
- Davidkin I, Peltola H, Leinikki P. Epidemiology of rubella in Finland. Euro Surveill. 2004;9(4):13–4.View ArticlePubMedGoogle Scholar
- NBS. Tanzania Demographic and Health Survey 2010. Dar es Salaam: 2011.Google Scholar
- UNICEF. Children and Women in Tanzania. Tanzania; Julie Pudlowski Consulting; 2010.Google Scholar
- Mwambe B, Mirambo MM, Mshana SE, Massinde AN, Kidenya BR, Michael D, Morona D, Majinge C, Groß U. Sero-positivity rate of rubella and associated factors among pregnant women attending antenatal care in Mwanza, Tanzania. BMC Pregnancy Childbirth. 2014;14(1):95.View ArticlePubMedPubMed CentralGoogle Scholar
- Peckham C, Tookey P, Hardelid P. Rubella epidemiology: surveillance to monitor and evaluate congenital rubella prevention strategies. Rubella Viruses. 2006;15:95.View ArticleGoogle Scholar
- Krugman S, Katz SL, Gershon AA. Infectious diseases of children. 1992.Google Scholar
- Manirakiza A, Kipela JM, Sosler S, Daba RM, Gouandjika-Vasilache I. Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic. BMC Public Health. 2011;11(1):327.View ArticlePubMedPubMed CentralGoogle Scholar
- Kombich JJ, Muchai PC, Tukei P, Borus PK. Rubella seroprevalence among primary and pre-primary school pupils at Moi's bridge location, Uasin Gishu District, Kenya. BMC Public Health. 2009;9(1):269.View ArticlePubMedPubMed CentralGoogle Scholar
- Sharma HJ, Padbidri VS, Kapre SV, Jadhav SS, Dhere RM, Parekh SS, Dudhane AD, Shewale SD, Namjoshi GS. Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India. J Infect Dev Ctries. 2011;5:12.View ArticleGoogle Scholar
- Mirambo MM, Majigo M, Aboud S, Groß U, Mshana SE. Serological makers of rubella infection in Africa in the pre vaccination era: a systematic review. BMC Res Notes. 2015;8(1):716.View ArticlePubMedPubMed CentralGoogle Scholar
- Vijayalakshmi P, Anuradha R, Prakash K, Narendran K, Ravindran M, Prajna L, Brown D, Robertson SE. Rubella serosurveys at three Aravind eye hospitals in Tamil Nadu, India. Bull World Health Organ. 2004;82(4):259–64.PubMedPubMed CentralGoogle Scholar
- Gupta E, Dar L, Broor S. Seroprevalence of rubella in pregnant women in Delhi, India. 2006.Google Scholar
- Roush SW, McIntyre L, Baldy LM. Manual for the surveillance of vaccine-preventable diseases. Atlanta: Centers for Disease Control and Prevention; 2008. p. 4.Google Scholar
- Mirambo MM, Chibwe E, Mushi MF, Majigo M, Mshana SE. Cytomegalovirus, Parvovirus B19 and Rubella Co-infection among Pregnant Women Attending Antenatal Clinics in Mwanza City: The Need to be considered in Tanzanian Antenatal Care Package. Epidemiology: Open Access. 2016;2016.Google Scholar
- Saajan AM, Nyindo M, Gidabayda JG, Abdallah MS, Jaffer SH, Mukhtar AG, Khatibu TM, Philemon R, Kinabo GD, Mmbagaa BT. TORCH Antibodies Among Pregnant Women and Their Newborns Receiving Care at Kilimanjaro Christian Medical Centre, Moshi, Tanzania. Health Res J. 2017;95.Google Scholar
- Levy PS, Lemeshow S. Sampling of populations: methods and applications. New York; Wiley; 2013.Google Scholar
- WHO. Rubella vaccines: WHO position paper—Recommendations. Vaccine. 2011;29(48):8767–8.View ArticleGoogle Scholar
- Banatvala J, Brown D. Rubella. Lancet. 2004;363(9415):1127–37.View ArticlePubMedGoogle Scholar
- Yadav S, Gupta S, Kumari S. Seroprevalence of rubella in women of reproductive age. Indian J Pathol Microbiol. 1995;38(2):139.PubMedGoogle Scholar
- Kanbur NO, Derman O, Kutluk T, Kinik E. Age specific rubella seroprevalence of an unvaccinated population of adolescents in Ankara, Turkey. Jpn J Infect Dis. 2003;56(1):23–5.PubMedGoogle Scholar
- Aksit S, Egemen A, Ozacar T, Kurugol Z, Keskinoglu P, Tasbakan M, Caglayan S. Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey. Pediatr Infect Dis J. 1999;18(7):577–80.View ArticlePubMedGoogle Scholar
- Oner N, Vatansever Ü, Karasalihoglu S, Tatman-Otkun M, Ekuklu G, Kucukugurluoglu Y. Rubella seroprevalence among Turkish adolescent girls living in Edirne, Turkey. Turk J Pediatr. 2006;48(4):288.PubMedGoogle Scholar
- Duszak RS. Congenital rubella syndrome—major review. Optometry. 2009;80(1):36–43.View ArticlePubMedGoogle Scholar
- Castillo-Solórzano C, Carrasco P, Tambini G, Reef S, Brana M, de Quadros CA. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J Infect Dis. 2003;187(Supplement 1):S146–52.View ArticlePubMedGoogle Scholar
- Irons B, Lewis MJ, Dahl-Regis M, Castillo-Solórzano C, Carrasco PA, De Quadros CA. Strategies to eradicate rubella in the English-speaking Caribbean. Am J Public Health. 2000;90(10):1545.View ArticlePubMedPubMed CentralGoogle Scholar
- Rustgi R, Deka D, Singh S. Rubella serology in Indian adolescent girls and its relation to socio-economic status. J Obstet Gynecol India. 2005;55(2):167–9.Google Scholar
- Aksakal FN, Maral I, Cirak MY, Aygun R. Rubella seroprevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey? Jpn J Infect Dis. 2007;60(4):157.PubMedGoogle Scholar